In a July 10, 2012 complaint, the SEC charged a Texas-based medical device company, Orthofix International N.V., with engaging in a seven-year bribery scheme involving its Mexican subsidiary Promeca S.A. de C.V. (Promeca). The SEC alleges that Promeca employees referred to the bribe payments, which totaled over $300,000, as “chocolates.”
-
- |